Overexpression of genes encoding glycolytic enzymes in Corynebacterium glutamicum enhances glucose metabolism and alanine production under oxygen deprivation conditions. 2012

Shogo Yamamoto, and Wataru Gunji, and Hiroaki Suzuki, and Hiroshi Toda, and Masako Suda, and Toru Jojima, and Masayuki Inui, and Hideaki Yukawa
Research Institute of Innovative Technology for the Earth (RITE), Kizugawadai, Kizugawa, Kyoto, Japan.

We previously reported that Corynebacterium glutamicum strain ΔldhAΔppc+alaD+gapA, overexpressing glyceraldehyde-3-phosphate dehydrogenase-encoding gapA, shows significantly improved glucose consumption and alanine formation under oxygen deprivation conditions (T. Jojima, M. Fujii, E. Mori, M. Inui, and H. Yukawa, Appl. Microbiol. Biotechnol. 87:159-165, 2010). In this study, we employ stepwise overexpression and chromosomal integration of a total of four genes encoding glycolytic enzymes (herein referred to as glycolytic genes) to demonstrate further successive improvements in C. glutamicum glucose metabolism under oxygen deprivation. In addition to gapA, overexpressing pyruvate kinase-encoding pyk and phosphofructokinase-encoding pfk enabled strain GLY2/pCRD500 to realize respective 13% and 20% improved rates of glucose consumption and alanine formation compared to GLY1/pCRD500. Subsequent overexpression of glucose-6-phosphate isomerase-encoding gpi in strain GLY3/pCRD500 further improved its glucose metabolism. Notably, both alanine productivity and yield increased after each overexpression step. After 48 h of incubation, GLY3/pCRD500 produced 2,430 mM alanine at a yield of 91.8%. This was 6.4-fold higher productivity than that of the wild-type strain. Intracellular metabolite analysis showed that gapA overexpression led to a decreased concentration of metabolites upstream of glyceraldehyde-3-phosphate dehydrogenase, suggesting that the overexpression resolved a bottleneck in glycolysis. Changing ratios of the extracellular metabolites by overexpression of glycolytic genes resulted in reduction of the intracellular NADH/NAD(+) ratio, which also plays an important role on the improvement of glucose consumption. Enhanced alanine dehydrogenase activity using a high-copy-number plasmid further accelerated the overall alanine productivity. Increase in glycolytic enzyme activities is a promising approach to make drastic progress in growth-arrested bioprocesses.

UI MeSH Term Description Entries
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D005798 Genes, Bacterial The functional hereditary units of BACTERIA. Bacterial Gene,Bacterial Genes,Gene, Bacterial
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006019 Glycolysis A metabolic process that converts GLUCOSE into two molecules of PYRUVIC ACID through a series of enzymatic reactions. Energy generated by this process is conserved in two molecules of ATP. Glycolysis is the universal catabolic pathway for glucose, free glucose, or glucose derived from complex CARBOHYDRATES, such as GLYCOGEN and STARCH. Embden-Meyerhof Pathway,Embden-Meyerhof-Parnas Pathway,Embden Meyerhof Parnas Pathway,Embden Meyerhof Pathway,Embden-Meyerhof Pathways,Pathway, Embden-Meyerhof,Pathway, Embden-Meyerhof-Parnas,Pathways, Embden-Meyerhof
D000409 Alanine A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM. Abufène,Alanine, L-Isomer,L-Alanine,Alanine, L Isomer,L Alanine,L-Isomer Alanine
D000693 Anaerobiosis The complete absence, or (loosely) the paucity, of gaseous or dissolved elemental oxygen in a given place or environment. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Anaerobic Metabolism,Anaerobic Metabolisms,Anaerobioses,Metabolism, Anaerobic,Metabolisms, Anaerobic
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions
D048230 Corynebacterium glutamicum A species of gram-positive, asporogenous, non-pathogenic, soil bacteria that produces GLUTAMIC ACID.
D053858 Metabolic Networks and Pathways Complex sets of enzymatic reactions connected to each other via their product and substrate metabolites. Metabolic Networks,Metabolic Pathways,Metabolic Network,Metabolic Pathway,Network, Metabolic,Networks, Metabolic,Pathway, Metabolic,Pathways, Metabolic
D060847 Metabolic Engineering Methods and techniques used to genetically modify cells' biosynthetic product output and develop conditions for growing the cells as BIOREACTORS. Engineering, Metabolic

Related Publications

Shogo Yamamoto, and Wataru Gunji, and Hiroaki Suzuki, and Hiroshi Toda, and Masako Suda, and Toru Jojima, and Masayuki Inui, and Hideaki Yukawa
August 2007, Microbiology (Reading, England),
Shogo Yamamoto, and Wataru Gunji, and Hiroaki Suzuki, and Hiroshi Toda, and Masako Suda, and Toru Jojima, and Masayuki Inui, and Hideaki Yukawa
June 2010, Applied microbiology and biotechnology,
Shogo Yamamoto, and Wataru Gunji, and Hiroaki Suzuki, and Hiroshi Toda, and Masako Suda, and Toru Jojima, and Masayuki Inui, and Hideaki Yukawa
January 2004, Journal of molecular microbiology and biotechnology,
Shogo Yamamoto, and Wataru Gunji, and Hiroaki Suzuki, and Hiroshi Toda, and Masako Suda, and Toru Jojima, and Masayuki Inui, and Hideaki Yukawa
April 2010, Applied microbiology and biotechnology,
Shogo Yamamoto, and Wataru Gunji, and Hiroaki Suzuki, and Hiroshi Toda, and Masako Suda, and Toru Jojima, and Masayuki Inui, and Hideaki Yukawa
August 2008, Applied and environmental microbiology,
Shogo Yamamoto, and Wataru Gunji, and Hiroaki Suzuki, and Hiroshi Toda, and Masako Suda, and Toru Jojima, and Masayuki Inui, and Hideaki Yukawa
September 2005, Applied microbiology and biotechnology,
Shogo Yamamoto, and Wataru Gunji, and Hiroaki Suzuki, and Hiroshi Toda, and Masako Suda, and Toru Jojima, and Masayuki Inui, and Hideaki Yukawa
February 2013, Applied and environmental microbiology,
Shogo Yamamoto, and Wataru Gunji, and Hiroaki Suzuki, and Hiroshi Toda, and Masako Suda, and Toru Jojima, and Masayuki Inui, and Hideaki Yukawa
June 2015, Applied microbiology and biotechnology,
Shogo Yamamoto, and Wataru Gunji, and Hiroaki Suzuki, and Hiroshi Toda, and Masako Suda, and Toru Jojima, and Masayuki Inui, and Hideaki Yukawa
March 2008, Applied microbiology and biotechnology,
Shogo Yamamoto, and Wataru Gunji, and Hiroaki Suzuki, and Hiroshi Toda, and Masako Suda, and Toru Jojima, and Masayuki Inui, and Hideaki Yukawa
February 2012, Applied and environmental microbiology,
Copied contents to your clipboard!